Overall, MALAT1 promotes the progress of NSCLC by regulating the miR-200a-3p/PD-L1 axis, which is of positive significance to the selection of new targeted drugs and the enrichment of therapeutic methods in the future. The gene discussed is CD274; the disease is non-small cell lung carcinoma.